These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 177190)

  • 21. Hepatoma: long-term survival with disseminated tumor treated with 5-fluorouracil.
    Ramirez G; Ansfield FJ; Curreri AR
    Am J Surg; 1970 Sep; 120(3):400-3. PubMed ID: 4318569
    [No Abstract]   [Full Text] [Related]  

  • 22. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
    Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous prolonged intrahepatic infusion of 5-fluorouracil in the treatment of hepatoma in Ibadan.
    Francis TI
    West Afr Med J Niger Pract; 1972 Feb; 21(1):18-20. PubMed ID: 4338412
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatoma in a child with methotrexate-induced hepatic fibrosis.
    Ruymann FB; Mosijczuk AD; Sayers RJ
    JAMA; 1977 Dec; 238(24):2631-3. PubMed ID: 200767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Flourouracil in hepatocellular carcinoma: report of twenty-one cases.
    Link JS; Bateman JR; Paroly WS; Durkin WJ; Peters RL
    Cancer; 1977 May; 39(5):1936-9. PubMed ID: 192441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous porphyria due to a malignant primary hepatoma.
    Thompson RP; Nicholson DC; Farnan T; Whitmore DN; Williams R
    Gastroenterology; 1970 Nov; 59(5):779-83. PubMed ID: 4319877
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatocellular carcinoma responding to chemotherapy with 5-FU.
    Yoshida H; Onda M; Tajiri T; Umehara M; Mamada Y; Taniai N; Kaneko M; Mizuguchi Y; Uchida E; Yamashita K; Uchida E
    Hepatogastroenterology; 2000; 47(34):1120-1. PubMed ID: 11020893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma.
    Petrini I; Lencioni M; Ricasoli M; Iannopollo M; Orlandini C; Oliveri F; Bartolozzi C; Ricci S
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):773-80. PubMed ID: 22033636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum alpha-fetoprotein as a biochemical marker for hepatocellular carcinoma.
    McIntire KR; Vogel CL; Princler GL; Patel IR
    Cancer Res; 1972 Sep; 32(9):1941-6. PubMed ID: 4116292
    [No Abstract]   [Full Text] [Related]  

  • 30. The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors.
    Kogure T; Ueno Y; Iwasaki T; Shimosegawa T
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):296-304. PubMed ID: 14689231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic combination chemotherapy for metastatic breast cancer.
    Biran S; Krasnokuki D; Hochman A; Brufman G
    Isr J Med Sci; 1977 Jun; 13(6):582-6. PubMed ID: 885710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Fluorouracil and leucovorin in hepatocellular carcinoma.
    van Eeden H; Falkson G; Burger W; Ansell SM
    Ann Oncol; 1992 May; 3(5):404-5. PubMed ID: 1319733
    [No Abstract]   [Full Text] [Related]  

  • 33. Surgery and adjuvant chemotherapy in the treatment of operable breast cancer.
    Rossi A; Valagussa P; Bonadonna G
    Prog Clin Biol Res; 1977; 12():391-404. PubMed ID: 335401
    [No Abstract]   [Full Text] [Related]  

  • 34. [Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
    Bedenne L; Chauffert B; Lorcerie B; Faivre J; Hillon P; Klepping C; Martin F
    Gastroenterol Clin Biol; 1989 Oct; 13(10):845-6. PubMed ID: 2556316
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of capecitabine use in patients with liver dysfunction.
    Saif MW; Tejani MA
    Clin Adv Hematol Oncol; 2007 Sep; 5(9):730-2; discussion 736. PubMed ID: 17982413
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intra-arterial chemotherapy of primary hepatoma and changes in -fetoprotein levels].
    Miura T; Sugimura M; Ishida M; Endo Y; Oda T
    Nihon Rinsho; 1972 May; 30(5):1201-8. PubMed ID: 4339908
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic cytostatic drug therapy in liver cancer.
    Glimelius B
    Ann Chir Gynaecol Suppl; 1986; 200():69-73. PubMed ID: 3014989
    [No Abstract]   [Full Text] [Related]  

  • 39. The surgical management of primary hepatocellular carcinoma in Uganda.
    Harrison NW; Dhru D; Primack A; Bhana D; Kyalwazi SK
    Br J Surg; 1973 Jul; 60(7):565-9. PubMed ID: 4352089
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy of Morris hepatoma 3924A: correlation of size and weight of tumor and preliminary data with 5-fluoro-2'-deoxyuridine (5-FUDR; NSC-27640).
    Lo KW; Miller EE; Morris HP; Tsou KC
    Cancer Chemother Rep; 1973; 57(3):245-9. PubMed ID: 4356394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.